Political reporting focuses on human behavior: both the messages candidates choose and how people respond. But in this year’s unconventional election cycle, traditional coverage alone only tells part of the story. Enter Bloomberg Politics, which is forging a new, data-driven journalistic approach.
Inspiring humanity begins at home. We focus our community efforts in all of our BlueCities in the United States, Caribbean and Latin America. Led by crewmembers, our community programs embody our values of caring, passion and fun. We partner with community based and national organizations on issues close to our heart including children’s literacy, community infrastructure and science, technology, engineering and math (STEM) and aviation education. Our support comes from donations, matching grants and crewmember volunteering.
TransCanada partnership awarded contract to build, own and operate Sur de Texas-Tuxpan natural gas pipeline in Mexico
MEXICO CITY, Mexico and CALGARY, Alberta, June 13, 2016 /3BL Media/ TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) today announced that its joint venture with IEnova, Infraestructura Marina del Golfo (IMG), has been chosen to build, own and operate the US$2.1 billion Sur de Texas-Tuxpan natural gas pipeline in Mexico. The project will be supported by a 25-year natural gas transportation service contract for 2.6 billion cubic feet a day with the Comisión Federal de Electricidad (CFE), Mexico's state-owned power company.
The formal signing of the Paris Agreement last week by 175 nations confirmed the commitment of the global community to implement large-scale climate change solutions. An unprecedented number of companies have also made groundbreaking commitments to reduce emissions and improve the resilience of their operations and communities.
- Building on the company's successful history in developing vaccines against similar viruses, most recently the introduction of Dengvaxia® against dengue, Sanofi Pasteur is launching a Zika vaccine project -
LYON, France, March 10, 2016 /3BL Media/ - Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
The Bristol-Myers Squibb Foundation is a global leader in promoting health equity and improving health outcomes for populations at high risk for serious diseases such as cancer, HIV and hepatitis C. To achieve long-term impact, the Foundation engages with governments and non-government organizations on seven global initiatives that strengthen community-based health programs and services. The Foundation is working with nearly 900 partners on more than 100 projects that are improving healthcare for nearly 1.5 million people worldwide.